BridgeMD
Compares treatment options for Seminoma
Official title Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
ClinicalTrials.gov ID: NCT05142982
What this study is testing
- What it's testing
- Testicular tumors account for 1% of all cancers in males and germ cell tumors comprise 95% of all testicular cancers. Seminomas consist of around 50% of cases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80, men only
You may be able to join if
- Histological diagnosis of classical seminoma
- Primary site - testis, mediastinum or retroperitoneum
- Stage IIB-IIIC (AJCC 8th edition)
- Age\>18 years
- Karnofsky Performance Status at least 70
You likely can't join if
- Histology other than classical seminoma
- Non completion of planned first-line chemotherapy
- Prior history of radiotherapy to the involved region
- Inability to deliver adequate radiotherapy dose safely based on assessment by radiation oncologist
See the full eligibility criteria
- Histological diagnosis of classical seminoma
- Primary site - testis, mediastinum or retroperitoneum
- Stage IIB-IIIC (AJCC 8th edition)
- Age\>18 years
- Karnofsky Performance Status at least 70
- A response assessment FDG PETCT scan done at least twelve weeks after the first line chemotherapy, showing a persistent measurable residual mass
- Patient willing and reliable for follow up and QOL.
- Histology other than classical seminoma
- Non completion of planned first-line chemotherapy
- Prior history of radiotherapy to the involved region
- Inability to deliver adequate radiotherapy dose safely based on assessment by radiation oncologist
The study team makes the final eligibility decision.
Where it's taking place
- Mumbai, Maharashtra, India
- Navi Mumbai, Maharashtra, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mumbai, Maharashtra, India; Navi Mumbai, Maharashtra, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.